WORK Medical Technology Group LTD — Proxy Solicitation & Information Statement 2026

Feb 10, 2026

6-K 1 ea0276157-01.htm CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

_____

FORM 6-K

_____

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2026

Commission File Number: 001 -42256

_____

WORK Medical Technology Group LTD

_____

Floor 23, No. 2 Tonghuinan Road Xiaoshan District, Hangzhou City, Zhejiang Province The People’s Republic of China (Address of principal executive offices)

_____

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20 -F or Form 40 -F .

Form 20 -F ☒ Form 40 -F ☐

EXPLANATORY NOTE

In connection with the annual general meeting of shareholders (the “Meeting”) of WORK Medical Technology Group LTD, an exempted company limited by shares incorporated under the laws of the Cayman Islands (the “Company”), the Company hereby furnishes the notice and proxy statement of the Meeting and the form of proxy card as Exhibits 99.1 and 99.2, respectively.

Exhibits

Exhibit No.	Description
99.1	Notice and Proxy Statement of the Meeting, dated February 9. 2026, to be mailed to shareholders of the Company in connection with the Meeting
99.2	Form of Proxy Card to be mailed to shareholders of the Company for use in connection with the Meeting

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: February 9, 2026

WORK Medical Technology Group LTD
By:	/ s / Shuang Wu
Name:	Shuang Wu
Title:	Chief Executive Officer

2